6Karyotype versus Phenotype in Turner SyndromeThere is some correlations but karyotypes are not predictive of what any particular girl with TS will have45XO most common and severest phenotype (highest incidence of cardiac, renal abnormalities and other dysmorphic features)
7Karyotype versus Phenotype in Turner Syndrome45XO/46XX Some cells have normal XX and some have XO (often called a mosaic pattern as two distinct cell lines).The frequency of each cell line can vary from tissue to tissue- this can change the phenotype.Generally the least severe phenotype.Increased mean height and spontaneous puberty in up to 40%.
11Karyotype versus Phenotype in Turner Syndrome46Xr(X) Ring Chromosome – often small and can be a mosaic pattern (ie not in all cells)Spontaneous periods in 33%.Congenital abns uncommon.Intellectual dysfunction in those with a small ring chromosome.
12Karyotype versus Phenotype in Turner Syndrome45X/46XY Have male karyotype in some cells (46XY). Often taller and there is an increased risk of gonadal tumour.
13Imprinting – what is it and what does it mean for Turner Syndrome? We all possess two alleles for each gene product – one from our mother and one from our father.In most genes the end result is the combination of these two alleles (eg handedness).In some genes, especially those related to growth one allele is permanently turned off. This occurs at or soon after fertilisation and is called imprinting.
14‘X Inactivation’Imprinting also occurs on the X chromosome. One half of the X chromosomes are randomly inactivated (ie roughly half maternal and half paternal)However in 45XO there is only one chromosome - this is usually maternal (~70%) but can be paternal (~30%) in origin.Does inheriting only one parents chromosome change the phenotype seen in TS?
15Parent of Origin Effects Personality/ learning – One British studyMaternal X- poorer verbal skills- poorer sociobehavioural skillsNot substantiated in several subsequent studies.Nature; 37:705-08, 1997
16Parent of Origin Effects Growth – Several studies shown effects on growthMaternal X- maternal and midparental height- greater height gain with growth hormonePaternal X- weakly associated with parents height.- poorer final height.JCEM 91: , 2006Genetics and Molecular Research 6(1):1-7, 2007
17Parent of Origin Effects Hearing Loss – one recent studyPaternal X- Strongly associated with an increased risk of hearing impairment.Of 50 subjects, 23 (46% had sensorineural hearing loss (SNHL)).12 of 18 with Xpat (67%) had SNHL versus 11 of 32 Xmat (34%).JCEM 91: , 2006
18Parent of Origin Effects Kidneys and eyesMaternal X- all renal abnormalities occurred in this groupPaternal X- ocular problems more commonJCEM 92: , 2007
19Parent of Origin Effects Metabolism – two recent studiesMaternal X- Increased total abdominal and visceral fat accumulation.- more atherogenic lipid profile.JAMA March 22/29 (12); 295, , 2006JCEM 92: , 2007
20Body Composition Altered in adult TS (42.5 ± 9.7 years) showing: Increased fat mass including increased visceral fat.Reduced muscle mass.Reduced exercise capacity.n=55n=54European J of Endocrinology,155:
21Body Composition Effect of growth hormone Increased lean and bone mass Reduced fat massEffects independent of oestrogen and still apparent > one year after finishing growth hormone.JCEM 91: , 2006n=2812.8 yrsn=3911.9 yrs
22Body Composition Effect of oestrogen replacement IM or transdermal oestrogen may result in reduced fat mass accumulation.Spray on gel (17b oestradiol) used in young lean adult TS women (n=9, 23 years) for 1 year.Total lean mass increased by 1kg compared to oral HRT group with no significant change in fat mass between groups.The route of administration may be more important than previously considered – watch this space.Gynecological Endocrinology, 22(10): , 2006
23Oestrogen route and growth Oestrogen route of administration may affect puberty growth spurt.A small study examined giving IM oestradiol to 7 TS at either years or years. Predicted height in both groups was cm. All received growth hormone.Final height was 154 cm in the early pubertal induction group and cm in the late pubertal induction groupJCEM, 90:
24Oestrogen route and growth This equates to a pubertal height gain of17.3 cm in the early oestrogen group15.0 cm in the late pubertal group11.4 cm after oral oestrogen therapy at 12 years age.Oral oestrogens have major effects on the liver which maty reduce pubertal growth. Transdermal oestrogen now available here –Watch this space!JCEM, 90:
25Cognition and Turner Syndrome ‘Non verbal disability’Characterised by- deficits in maths and science- Impaired performance in visuo-motor tasks that have a spatial component.- impaired adaptation to novel situations- impaired social competence- increased anxiety and depression- Increased ADHD (18 fold increase in TS)Hormone Research, 65: J Ped. Psychology31(9): , 2006
26Cognition and Turner Syndrome Therapeutic recommendations (by Harnadek and Rourke)J Learning Disability, 27:
27Cognition and Turner Syndrome a) Sex Steroid Effects on the Brainb) Lack of an X chromosome/ genes involved in neurocognitive development and behaviourc) Imprinting (? real)d) Environmental interactionsHormone Research, 65:
28Sex Steroid Effects Oestrogen Improves adult women’s verbal memory, articulatory speed and fine motor abilities.Oestrogen supplementation to young TS girls has improved verbal memory. Doesn’t improve spatial deficits.Hormone Research, 65:
29Sex Steroid Effects Androgen TS women are also androgen deficient. Higher testosterone levels in men and women associated with better spatial ability, mathematics and problem solving.Women tx with androgens after ovariectomy have improved memory, complex information processing and logical reasoning.Oxandrolone tx of TS girls improved working memory after 2 years of txHormone Research, 65:
30Haploinsufficiency (one chromosome) Most of the genes involved in neurocognitive and behaviour involve areas of the X chromosome that don’t get inactivated and there are usually two copies of the gene available.Therefore in TS there is a reduction in the gene dose and possible developmental; consequences as a result.Hormone Research, 65:
31EnvironmentShyness, social anxiety and impaired self esteem reduced equally in adults with TS (n=100, age 34.7 years) and women with premature ovarian failure (n=100, 30.9 years) and healthy controls (n=35, 35.8 years).Hormone Research, 65:
32Self reported psychosocial function and body image perception 30 TS women (age 22.1 years) matched to 44 non TS women (20.5 years).No difference on most scores including all behavioural and emotional problems.They perceived themselves as socially less competent.BMI was related to the appraisal score.Hormone Research, 66: 277:
34Self-Esteem and social adjustment – influence of pubertal management and sexuality French!566 young adult TS women ( years)Low self esteem associated with- hearing impairment- limited sexual experienceJCEM 91: , 2006
35Self-Esteem and Social Adjustment – influence of pubertal management and sexuality Low social adjustment associated with lower socio economic class and an absence of sexual experienceAge at pubertal development associated with age at first sexual experience.Delayed pubertal induction had a long lasting effect on sex life.JCEM 91: , 2006
37Turner Syndrome – Incidence, diagnostic delay and mortality Danish Cytogenetic register – 781 TS betweenIncidence: 50/100,000 (1:2000 female births)There was a delay in diagnosis with the mean age being 15.1 years! Although this is historical many patients still seem to be missed until their 20s.There is a decreasing age at diagnosis over the 30 years study period.JCEM 91: , 2006
39Turner Syndrome – mortality Overall mortality was increased compared to the general population (standardised mortality rate (SMR) 2.86 ~ almost 3 times the risk of dying)There was a karyotype risk withXO SMR=4.08isoXq SMR= 3.86other karyotypes SMR = 2.1JCEM 91: , 2006
41Turner Syndrome – mortality Commonest causes of deathCongenital abnormalities (probably mainly cardiac)Coronary artery diseaseMetabolic/ endocrine (eg inadequate HRT)DIABETES MELLITUS was a contributing cause of death in 22% of cases.JCEM 91: , 2006